InvestorsHub Logo

Skiluc

06/21/22 9:54 PM

#36508 RE: The Other Guy #36507

Easiest data to buy into if you have been following a single iota.

My question is do they miss the Q2 mark causing a buying dip! Im set either way!

cowtown jay

06/22/22 10:38 AM

#36512 RE: The Other Guy #36507

I'm with you on looking forward to the NIH topline data.

It's unfortunate that this wait has been so costly and unnecessary. We know that our
work on using CRP as a biomarker has been accepted for publication. I personally think that peer review is just as important to us as TLD. But I'll damn sure take the release of both.